Pure Global

IVD Cluster Bacterial Sensitivity Testing - Vietnam Registration 240001384/PCBB-HCM

Access comprehensive regulatory information for IVD Cluster Bacterial Sensitivity Testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240001384/PCBB-HCM and manufactured by BIOANALYSE TIBBİ MALZEME SANAYİ VE TİCARET LİMİTED ŞİRKETİ. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ KHOA HỌC KỸ THUẬT QUANG PHÁT.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240001384/PCBB-HCM
Registration Details
Vietnam MOH Registration: 240001384/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Cluster Bacterial Sensitivity Testing
VN: Cụm IVD Xét nghiệm tính mẫn cảm của vi khuẩn
theo phụ lục
Risk Class TTBYT Loại B

Registration Details

240001384/PCBB-HCM

000.00.19.H29-240628-0012

Theo theo phụ lục

Theo phụ lục

Company Information

BIOANALYSE TIBBİ MALZEME SANAYİ VE TİCARET LİMİTED ŞİRKETİ

Technical Details

The susceptibility test disk, designed for use in clinical laboratories and used manually with the diffusion semiquantitative test method, is used to support clinical physicians in the management of patients and to determine potential treatment options in patients suspected of being infected with bacteria. It can be used in infections caused by difficult-to-grow and/or easily grown bacteria. It is prepared on a pure agar medium using standard strains and/or can be used for quality control purposes. The test provides information to classify bacteria as resistant, moderately susceptible, or susceptible to antibiotics.

Dates and Status

Jul 03, 2024